Buy Crypto Markets Spot FuturesUNITREE Earn Event Centre Rewards Hub

Latigo Biotherapeutics, Inc. (LTGO)

NASDAQ

$18.80

$+0.43

(+2.37%)

Market Closed

Latigo Biotherapeutics, Inc. (LTGO) Live Price Chart

Last updated: ⁦2026-08-12 13:03:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Key Market Data

Market Cap	--
Open	$18.37
High	$22.47
Low	$17.22
Previous Close	$18.52
Price Change	$+0.43
Percentage Change	+2.37%
Volume	573

Latigo Biotherapeutics, Inc. (LTGO) Stock Price Today

Latigo Biotherapeutics, Inc. (LTGO) is currently trading at $18.80 as of 2026-08-12 12:53:00, reflecting a +2.37% move ($+0.43) from the previous close.

In the short term, the stock has returned +3.04% over the past four weeks. Over the last 12 months, Latigo Biotherapeutics, Inc. has recorded a +3.04% price change, indicating a Stable performance relative to the broader market.

Latigo Biotherapeutics, Inc. (LTGO) 7-Day Stock Price Changes

Over the past seven days, Latigo Biotherapeutics, Inc. has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $21.00 to the latest recorded price of $18.80, reflecting an intraday change of +2.37%. Daily movements highlight shifts in trading volume (573), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, LTGO has delivered a +3.04% return over the past month and a +3.04% change in the last 12 months, indicating a Stable trend relative to its broader sector peers.

How to Buy Latigo Biotherapeutics, Inc. (LTGO)

You can buy and trade LTGO on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for LTGO and Execute Your Trade

Open the trading page, enter LTGO in the search bar, select the amount of LTGO you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Latigo Biotherapeutics, Inc. (LTGO)?

Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.

Latigo Biotherapeutics, Inc. Information

Industry	--
Employees	--
Sector	--
Company Website	https://www.latigobio.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Latigo Biotherapeutics, Inc.?

The latest trading price for Latigo Biotherapeutics, Inc. (Common Stock) is $ 18.80, compared with a previous closing price of $ 18.52. That means the stock has moved +2.37% so far today. Intraday price updates and recent trading activity for LTGO can be tracked on the live chart and quote section on this page.

2.Is Latigo Biotherapeutics, Inc. stock going up or down?

Looking at recent performances, LTGO has returned +3.04% over the past month, +3.04% over the last six months and +3.04% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe Stable price momentum for Latigo Biotherapeutics, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does LTGO currently sit relative to its 52-week high and low?

In the most recent 52-week period, Latigo Biotherapeutics, Inc. has traded between a low of $ 17.22 and a high of $ 22.47. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether LTGO is currently nearer the top or the bottom of its one-year trading band.

4.How is Latigo Biotherapeutics, Inc. classified by sector and industry?

Latigo Biotherapeutics, Inc. is classified in the -- sector. In practice, this means Latigo Biotherapeutics, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing LTGO’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the -- sector could influence Latigo Biotherapeutics, Inc.’s performance.

5.Where is Latigo Biotherapeutics, Inc. listed and how large is it by market value?

Latigo Biotherapeutics, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalisation of --, the company is classified as a Small-cap stock. Market cap gives a quick sense of Latigo Biotherapeutics, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does LTGO's EPS tell investors about its profitability?

Trailing-twelve-month EPS of -- summarises how much profit Latigo Biotherapeutics, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Latigo Biotherapeutics, Inc.'s financial performance over time?

To follow Latigo Biotherapeutics, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how LTGO is performing and how the market is responding.

8.When is Latigo Biotherapeutics, Inc. expected to report earnings?

Latigo Biotherapeutics, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for LTGO, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Latigo Biotherapeutics, Inc.'s earnings reports?

Latigo Biotherapeutics, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether LTGO is meeting, beating or missing expectations.

10.How can I stay informed about Latigo Biotherapeutics, Inc.'s results and guidance?

You can stay up to date on Latigo Biotherapeutics, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for LTGO on this page helps you see how new information is being reflected in the stock.

11.Does Latigo Biotherapeutics, Inc. pay a regular cash dividend to its shareholders?

Latigo Biotherapeutics, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of -- at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor LTGO's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for LTGO?

Based on the latest earnings data, LTGO has a dividend yield of -- and a dividend payout ratio of --. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Latigo Biotherapeutics, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Latigo Biotherapeutics, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Latigo Biotherapeutics, Inc.?

Latigo Biotherapeutics, Inc. is a publicly traded company in the -- industry within the -- sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is LTGO valued in terms of P/E ratio and EPS?

Latigo Biotherapeutics, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of --. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Latigo Biotherapeutics, Inc.'s earnings. Comparing LTGO's P/E and EPS to those of other -- companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalisation

Most Actively Traded

Discover today's most actively traded US stocks

CrowdStrike Holdings, Inc.

CRWD

Marvell Technology, Inc.

MRVL

American Express Company

AXP

International Business Machines Corporation

IBM

Amphenol Corporation

APH

Top Gainers

Browse today's leading gainers in the US stock market

Energy Vault Holdings, Inc.

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalisation

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

MEXC Aug 8: Share $500K

Refer friends early to earn 888% APR and $3,888

LTGO-to-USD Calculator

Amount

LTGO

USD

1 LTGO = 18.804 USD